Specialty Areas
- Urologic oncology
- Robotic surgery
Common Procedures
- Nerve-sparing Robotic Prostatectomy
- Transperineal Micro-Ultrasound and MRI-Fusion Prostate Biopsy
- Robotic Cystectomy with Intracorporeal Diversion
Common Diagnoses Treated
- Prostate cancer
- Elevated PSA
- Bladder cancer
Board Certifications
American Board of Urology
Degrees
Medical School: Washington University School of Medicine, St. Louis, MO, 2012
Residency
2017, Urology Residency, Washington University School of Medicine, St. Louis, MO
Fellowship
2018, Minimally Invasive Urologic Oncology Fellowship, Washington University School of Medicine, St. Louis, MO
Professional Memberships
American Urological Association
American Board of Urology
Society of Urologic Oncology
Awards, Activities and Honors
- 2008 Summa Cum Laude, Rice University
- 2008 Phi Beta Kappa Honors Society, Rice University
- 2008 Albert F. Koetter, M.D. Full Tuition Merit Scholarship, Washington University School of Medicine
- 2012 Alpha Omega Alpha, Washington University School of Medicine
- 2014 Certificate of Scholarship, Division of Urology, Washington University School of Medicine
- 2015 Certificate of Scholarship, Division of Urology, Washington University School of Medicine
- 2015 2nd Place Presentation, Patient Safety Quality Improvement Symposium, Barnes Jewish Hospital
- 2016 Resident in Excellence (voted by faculty), Urology, Washington University School of Medicine
- 2016 Isadore M. Wayne Memorial Scholarship, The Empowerment Network Inc., St. Louis, MO
- 2016 Top Reviewer, Urologic Oncology: Seminars and Original Investigations
- 2017 Resident in Excellence (voted by faculty), Urology, Washington University School of Medicine
- 2020 American Urological Association/European Association of Urology International Academic Exchange Program Scholar
- 2021 Charles B. Manley Teaching Award (voted by residents), Division of Urology, Washington University School of Medicine
- 2022 Finalist for the American Urological Association Early Career Investigators Showcase
Areas of Research
- Prostate Cancer Imaging and Biomarkers
- Robotic Prostatectomy Techniques and Outcomes
- Robotic Cystectomy Techniques and Outcomes
Clinical Trials
- Prostate Cancer Imaging Trials: LOCATE, SPOTLIGHT/LIGHTHOUSE
- Prostate Cancer Treatment: PROTEUS, CellVax Post-Prostatectomy Autologous Cellular Vaccination
Innovations
- Use of MRI in combination with liquid biomarkers to determine which men should undergo prostate biopsy for suspected prostate cancer
- Development of Diffusion Histology Imaging (NIH funded R01 CA258690-01A1) to perform virtual biopsy using artificial intelligence approaches to MRI interpretation
- Single port robotic prostatectomy and cystectomy
Publications
Kim EH, Andriole GL, Crawford ED, et al. Detection of high-grade prostate cancer among PLCO participants using a prespecified four kallikrein marker panel. Journal of Urology 2017; 197: 1041-1047. PMCID: PMC5386792
Kim EH, Weaver JK, Shetty AS, et al. Magnetic resonance imaging provides added value to the prostate cancer prevention trial risk calculator for patients with estimated risk of high grade prostate cancer less than or equal to 10%. Urology 2017; 102: 183-189. PMID: 27919668
Wang RS, Kim EH, Vetter JM, et al. Determination of the role of negative magnetic resonance imaging of the prostate in clinical practice: is biopsy still necessary? Urology 2017; 102: 190-197. PMID: 27845218
Bhat NR, Vetter JM, Andriole GL,…Kim, EH. Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy. Urology 2019; 126: 152-157. PMID: 30580005
Pickersgill NA, Vetter JM, Raval NS,…Kim, EH. The accuracy of prostate magnetic resonance imaging interpretation: impact of the individual radiologist and clinical factors. Urology 2019; 127: 68-73. PMID: 30807773
Weaver JK, Kim EH, Vetter JM, et al. Prostate magnetic resonance imaging provides limited incremental value over the Memorial Sloan Kettering Cancer Center preradical prostatectomy nomogram. Urology 2018; 113: 119-128.
Pickersgill NA, Vetter JM, Andriole GL,… Kim EH. Accuracy and variability of prostate multiparametric magnetic resonance imaging interpretation using the Prostate Imaging Reporting and Data System: a blinded comparison of radiologists. Eur Urol Focus 2020 6(2):267-272 PMID: 30327280
Henning GM, Vetter JM, Drake BF,… Kim EH. Diagnostic performance of prostate multiparametric magnetic resonance imaging in African-American men. Urology 2019; 134: 181-185. PMID: 31419432
Kim EH, Vemana G, Johnson MH, et al. Magnetic resonance imaging-targeted versus conventional Transrectal ultrasound-guided prostate biopsy: single institution, matched cohort comparison. Urologic Oncology 2015; 33(3): 109.e1-109.e6. PMID: 25655682
Monda SM, Vetter JM, Andriole GL,…Kim EH. Cognitive versus software fusion for MRI targeted biopsy: experience before and after implementation of fusion. Urology 2018; 119: 115-120. PMID: 29940232
Meng Y, Vetter JM, Andriole GL,…Kim EH. Improved detection of clinically significant prostate cancer with MR/US fusion in biopsy-naïve patients with negative prostate MRI. Urology 2018; 120: 162-166. PMID: 29958965
Henning GM, Vetter JM, Sterling JA,…Kim EH. Factors associated with higher prostate biopsy yield: when is software-assisted fusion MRI-targeting necessary? Urol Oncol 2021; 39: 234.e15-19. PMID: 33353869
Hospital Affiliations
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
Patients Seen At
Center for Advanced Medicine
4921 Parkview Place
Floor 11, Suite C
St. Louis, MO 63110
Barnes-Jewish West County Hospital
1044 N. Mason Road
Medical Building 4, Suite 230
Creve Coeur, MO 63141
To request an appointment with Dr. Kim, please call (314) 362-8200. If you have a new diagnosis of prostate, kidney, or bladder cancer and would like to be seen right away, please call (314) 273-1294, and leave a message with the assistant. We will do our best to accommodate you.
- English
- Korean